Core Insights - Carbon Cloud Intelligent, a unicorn in the life sciences sector, celebrated its 10th anniversary and outlined its vision for the digital life industry ecosystem at a product launch event in Zhuhai [1][3] - The company introduced its groundbreaking "Carbon Cloud Seven Core" silicon-based biochip technology, which is expected to revolutionize life sciences research and applications [3][4] Technology and Product Launch - The "Carbon Cloud Seven Core" series of biochips utilizes advanced "photolithography-in-situ synthesis technology" to manufacture on 8-inch silicon wafers, allowing for the synthesis of up to 168 million different probes within 15 hours [4] - This technology reduces detection costs by over 90% while significantly enhancing detection throughput and coverage [4] - The biochips cover seven core dimensions including genes, transcription, methylation, microbiomes, proteins, antibodies, and molecular interactions, enabling the creation of high-resolution digital life profiles from a single sample [4] Market Applications - For research institutions and pharmaceutical companies, Carbon Cloud Intelligent's "Carbon Cloud Smart Peptide" platform transforms drug development by utilizing peptide chips and AI models to generate high-quality candidate molecules, improving research efficiency [4] - In clinical diagnostics, the "Carbon Cloud Crystal Core" enhances cfDNA tumor mutation detection sensitivity to a low frequency of 1 in 100,000, with minimal sample requirements [5] - The "Carbon Cloud Health" division offers a digital health management platform that provides personalized health assessments and interventions, along with 24/7 health consulting services [5] Strategic Initiatives - The company announced plans to build and open a "Global Digital Life Ecosystem," aiming to collaborate with various partners including insurance companies, health check centers, traditional Chinese medicine, cell therapy, and pet healthcare sectors [5]